Particle Characterization of MSC Exosomes: NTA, TEM & Flow Cytometry
An exosome preparation is only as credible as the data that characterizes it. Because “exosomes” is a label, not a guarantee, the analytical methods used to measure them determine whether a research material can be trusted and reproduced. This guide explains the core characterization techniques — what each measures, what it cannot, and why a combination is the standard. Educational and research-use-only; no treatment claims.
What characterization establishes
Robust characterization answers three questions about a vesicle preparation: How many? (concentration), How big? (size distribution), and What are they? (identity markers and morphology). The research community’s reference framework for reporting this is MISEV (Minimal Information for Studies of Extracellular Vesicles), published by the International Society for Extracellular Vesicles, which recommends multiple complementary methods rather than reliance on any single one.
Core characterization methods
| Method | What it measures | Strengths | Limitations |
|---|---|---|---|
| NTA (Nanoparticle Tracking Analysis) | Particle size distribution & concentration | Fast, quantitative, works in solution | Cannot distinguish exosomes from other particles of similar size |
| TEM (Transmission Electron Microscopy) | Morphology & size of individual vesicles | Direct visualization of the classic cup-shaped morphology | Low throughput; sample prep can affect appearance |
| Flow Cytometry | Surface markers on vesicles/populations | Marker-based identity; high throughput | Small EVs near detection limits; needs careful controls |
| Western Blot / Protein markers | Presence of EV-associated proteins (e.g., CD9, CD63, CD81, TSG101) | Confirms vesicle identity markers | Bulk measurement, not single-particle |
| DLS (Dynamic Light Scattering) | Bulk size distribution | Quick screen | Biased by larger particles; lower resolution than NTA |
Why no single method is enough
Each technique has blind spots. NTA counts and sizes particles but cannot prove they are exosomes; TEM shows morphology but is low-throughput; flow cytometry and protein markers confirm identity but not single-particle counts. This is why MISEV-aligned reporting calls for orthogonal methods — combining a sizing/counting method, an imaging method, and a marker-based identity method to build a defensible picture.
Identity markers to look for
Commonly reported exosome/EV-associated proteins include tetraspanins (CD9, CD63, CD81) and cytosolic proteins such as TSG101 and ALIX, alongside assessment for the absence of common contaminants. Reporting both presence of expected markers and absence of contaminants is part of rigorous characterization.
What this means when sourcing
A credible supplier provides characterization data per lot — not just a product name. At minimum, expect particle size and concentration (e.g., by NTA), identity confirmation, and sterility/endotoxin screening, summarized in a per-lot Certificate of Analysis. The published methods behind these measurements are reflected throughout our MSC Exosome Research Library.
Frequently Asked Questions
What is the best way to characterize exosomes?
There is no single best method. Rigorous, MISEV-aligned characterization combines a counting/sizing method (e.g., NTA), an imaging method (e.g., TEM), and marker-based identity (e.g., flow cytometry or protein markers).
What markers identify exosomes?
Commonly reported markers include tetraspanins CD9, CD63, and CD81, plus cytosolic proteins like TSG101 and ALIX, alongside checks for the absence of contaminants.
What does NTA measure?
Nanoparticle Tracking Analysis measures particle size distribution and concentration in solution, but cannot by itself confirm that particles are exosomes.
These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical or legal advice.